Price T Rowe Associates Inc Sarepta Therapeutics, Inc. Transaction History

Price T Rowe Associates Inc

  • $869 Billion
  • Q3 2024

A detailed history of Price T Rowe Associates Inc transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 236,533 shares of SRPT stock, worth $28.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
236,533
Previous 340,030 30.44%
Holding current value
$28.1 Million
Previous $53.7 Million 45.01%
% of portfolio
0.0%
Previous 0.01%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$124.33 - $156.75 $12.9 Million - $16.2 Million
-103,497 Reduced 30.44%
236,533 $29.5 Million
Q2 2024

Aug 14, 2024
SELL
$113.33 - $163.85 $18.7 Million - $27 Million
-164,938 Reduced 32.66%
340,030 $53.7 Million
Q1 2024

May 15, 2024
SELL
$93.7 - $141.53 $22 Million - $33.2 Million
-234,768 Reduced 31.74%
504,968 $65.4 Million
Q4 2023

Feb 14, 2024
SELL
$67.31 - $124.76 $3.25 Million - $6.02 Million
-48,220 Reduced 6.12%
739,736 $71.3 Million
Q3 2023

Nov 14, 2023
BUY
$102.5 - $123.59 $721,087 - $869,455
7,035 Added 0.9%
787,956 $95.5 Million
Q2 2023

Aug 14, 2023
SELL
$106.4 - $157.19 $41.6 Million - $61.4 Million
-390,521 Reduced 33.34%
780,921 $89.4 Million
Q1 2023

May 15, 2023
BUY
$117.53 - $155.99 $39.3 Million - $52.2 Million
334,749 Added 40.01%
1,171,442 $161 Million
Q4 2022

Feb 14, 2023
SELL
$100.86 - $132.13 $38.5 Million - $50.5 Million
-382,178 Reduced 31.36%
836,693 $108 Million
Q3 2022

Nov 14, 2022
BUY
$75.71 - $119.24 $4.17 Million - $6.56 Million
55,024 Added 4.73%
1,218,871 $135 Million
Q2 2022

Aug 15, 2022
BUY
$62.69 - $88.44 $1.7 Million - $2.39 Million
27,042 Added 2.38%
1,163,847 $87.2 Million
Q1 2022

May 16, 2022
BUY
$63.15 - $90.42 $25.3 Million - $36.3 Million
401,247 Added 54.55%
1,136,805 $88.8 Million
Q4 2021

Feb 14, 2022
BUY
$77.28 - $99.42 $2.02 Million - $2.6 Million
26,114 Added 3.68%
735,558 $66.2 Million
Q3 2021

Nov 15, 2021
SELL
$65.97 - $92.48 $775,015 - $1.09 Million
-11,748 Reduced 1.63%
709,444 $65.6 Million
Q2 2021

Aug 16, 2021
BUY
$69.38 - $86.75 $1.18 Million - $1.48 Million
17,039 Added 2.42%
721,192 $56.1 Million
Q1 2021

May 17, 2021
SELL
$72.25 - $168.95 $43.2 Million - $101 Million
-598,498 Reduced 45.94%
704,153 $52.5 Million
Q4 2020

Feb 16, 2021
BUY
$125.56 - $178.74 $164 Million - $233 Million
1,302,651 New
1,302,651 $222 Million

Others Institutions Holding SRPT

# of Institutions
529
Shares Held
84.2M
Call Options Held
2.06M
Put Options Held
1.52M
View Full List

About Sarepta Therapeutics, Inc.

SRPT Quotes by TradingView
  • Ticker SRPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,567,904
  • Market Cap $10.4B
  • Description
  • Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...
More about SRPT
Track This Portfolio

Track Price T Rowe Associates Inc Portfolio

Follow Price T Rowe Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email